Pubblicazioni

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

2016 - MULTIPLE SCLEROSIS

Macdonell, Richard; Nagels, Guy; Laplaud, David-Axel; Pozzilli, Carlo; De Jong, Brigit; Martins Da Silva, Ana; Nicholas, Richard; Lechner-Scott, Jeannette; Gaebler, Julia A.; Agarwal, Sonalee; Wang, Ping; Yeh, Michael; Hovenden, Maria; Soelberg SÃ¸rensen, Per

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)

2016 - MULTIPLE SCLEROSIS

Lanzillo, Roberta; Quarantelli, Mario; Pozzilli, Carlo; Trojano, Maria; Amato, Maria Pia; Marrosu, Maria G.; Francia, Ada; Florio, Ciro; Orefice, Giuseppe; Tedeschi, Gioacchino; Bellantonio, Paolo; Annunziata, Pasquale; Grimaldi, Luigi M.; Comerci, Marco; Brunetti, Arturo; Bonavita, Vincenzo; Alfano, Bruno; Marini, Stefano; Brescia Morra, Vincenzo

Pubblicazioni

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)